A study of MSC-1, humanized antibody in several cancerous tumor types

Trial Profile

A study of MSC-1, humanized antibody in several cancerous tumor types

Planning
Phase of Trial: Phase I

Latest Information Update: 19 Jan 2017

At a glance

  • Drugs MSC 1 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jan 2017 New trial record
    • 19 Dec 2016 According to a Northern Biologics media release, this study is expected to initiate in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top